Predictions
National Cinemedia Inc.
Start price
Target price
Perf. (%)
€0.25
30.04.23
30.04.23
-
30.04.24
30.04.24
19.92%
01.05.24
01.05.24
Neptune Wellness Solutions Inc
Start price
Target price
Perf. (%)
€0.44
30.04.23
30.04.23
-
30.04.24
30.04.24
-70.95%
01.05.24
01.05.24
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€0.43
30.04.23
30.04.23
-
30.04.24
30.04.24
-47.00%
01.05.24
01.05.24
Security National Financial Corp.
Start price
Target price
Perf. (%)
€6.60
30.04.23
30.04.23
-
30.04.24
30.04.24
-14.39%
01.05.24
01.05.24
UTStarcom Holdings Corp.
Start price
Target price
Perf. (%)
€3.38
30.04.23
30.04.23
-
30.04.24
30.04.24
-28.99%
01.05.24
01.05.24
Acorda Therapeutics Cdt
Start price
Target price
Perf. (%)
€0.41
29.04.23
29.04.23
-
29.04.24
29.04.24
10.78%
30.04.24
30.04.24
Mammoth Energy Services Inc
Start price
Target price
Perf. (%)
€3.28
29.04.23
29.04.23
-
29.04.24
29.04.24
-9.76%
30.04.24
30.04.24
Vallourec S.A.
Start price
Target price
Perf. (%)
€10.15
29.04.23
29.04.23
€20.00
29.04.24
29.04.24
64.61%
30.04.24
30.04.24
Could be worthwhile Investment >10% per year
Addus Homecare Corp.
Start price
Target price
Perf. (%)
€79.50
29.04.23
29.04.23
€97.00
29.04.24
29.04.24
8.81%
30.04.24
30.04.24
Could be worthwhile Investment >10% per year
Viking Therapeutics Inc
Start price
Target price
Perf. (%)
€83.00
03.03.24
03.03.24
€180.00
31.05.26
31.05.26
-16.27%
29.04.24
29.04.24
Could be very worthwhile Investment >20% year
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€0.98
04.02.24
04.02.24
€1.50
31.10.25
31.10.25
14.29%
29.04.24
29.04.24
Could be very worthwhile Investment >20% year
ImmunityBio Inc.
Start price
Target price
Perf. (%)
€2.30
29.10.23
29.10.23
€4.00
30.06.26
30.06.26
247.39%
29.04.24
29.04.24
Could be very worthwhile Investment >20% year
Abeona Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.91
28.06.23
28.06.23
€7.00
31.01.26
31.01.26
-20.20%
28.04.24
28.04.24
Could be very worthwhile Investment >20% year
Plug Power Inc.
Start price
Target price
Perf. (%)
€2.91
08.04.24
08.04.24
€3.00
08.04.25
08.04.25
-21.66%
27.04.24
27.04.24
Good rating
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation